Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  25 نتائج ل ""DOXORUBICIN""

فلترة النتائج

Collection : Lilloa (Hal Lille Open Archive, Universite De Lille)
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery

Subjects: doxorubicin plus trabectedin; first-line chemotherapy; leiomyosarcoma

  • Source: ISSN: 2059-7029 ; ESMO Open ; https://amu.hal.science/hal-03623631 ; ESMO Open, 2021, 6 (4), pp.100209. ⟨10.1016/j.esmoop.2021.100209⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial.

Subjects: [SDV]Life Sciences [q-bio]

  • Source: ISSN: 1470-2045.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Phase I dose escalation study of 12b80 (hydroxybisphosphonate linked doxorubicin) in naturally occurring osteosarcoma.

Subjects: [SDV]Life Sciences [q-bio]

  • Source: ISSN: 1949-2553 ; Oncotarget ; https://hal.univ-lille.fr/hal-04413195 ; Oncotarget, 2021, Oncotarget, 11, pp.4281-4292. ⟨10.18632/oncotarget.27801⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Enzymatically Activated Glyco-Prodrugs of Doxorubicin Synthesized by a Catalysis-Free Diels–Alder Reaction

Subjects: [CHIM]Chemical Sciences

  • Source: ISSN: 1043-1802.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Regosarc: regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-a quality-adjusted time without symptoms of progression or toxicity analysis

Subjects: Mesh:Severity of Illness Index; Mesh:Sarcoma; Mesh:Synovial/drug therapy

  • Source: ISSN: 0008-543X.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry

Subjects: DEM-TACE; doxorubicin; hepatobiliary toxicities

  • Source: ISSN: 2072-6694.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)

Subjects: France; Mutation; Cell Line

  • Source: ISSN: 1949-2553 ; Oncotarget ; https://hal.science/hal-01812676 ; Oncotarget, 2016, 7, pp.2889-2909. ⟨10.18632/oncotarget.3898⟩.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.

Subjects: IMPROVED SURVIVAL; UNITED-STATES; PHASE-III

  • Source: ISSN: 0390-6078.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/ DSHNHL analysis.

Subjects: [SDV]Life Sciences [q-bio]

  • Source: ISSN: 2473-9529.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The ECHELON-2 Trial: 5-year results of a randomized, phase 3 study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma.

Subjects: brentuximab vedotin; CHOP; frontline treatment

  • Source: ISSN: 0923-7534.

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  25 نتائج ل ""DOXORUBICIN""